LCP1 was correlated with lymph node metastasis and proposed as independent PC prognostic factor (Chen et al., 2017), while GLO1 might serve as a high-grade prostatic intraepithelial neoplasia marker (Rounds et al., 2021) and is strongly linked to early biochemical recurrence (Burdelski et al., 2017). The gene discussed is GLO1; the disease is metastatic malignant neoplasm in the lymph nodes.